Welcome to LookChem.com Sign In|Join Free

CAS

  • or

32741-05-2

Post Buying Request

32741-05-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

32741-05-2 Usage

General Description

2-Isobutylthiophene is a chemical compound with the molecular formula C10H14S. It is a colorless to pale yellow liquid with a strong, pungent odor. This chemical is primarily used as a flavoring agent in the food industry, providing a strong, pungent, and sulfurous odor and taste to various food products. It is also used in the production of fragrances and as an intermediate in the synthesis of pharmaceuticals and other organic compounds. Additionally, 2-Isobutylthiophene is utilized in the manufacturing of agricultural products and insecticides due to its strong odor and aromatic properties. However, exposure to this chemical should be limited as it can cause irritation to the skin, eyes, and respiratory system, and may have adverse effects on human health if not handled properly.

Check Digit Verification of cas no

The CAS Registry Mumber 32741-05-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,2,7,4 and 1 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 32741-05:
(7*3)+(6*2)+(5*7)+(4*4)+(3*1)+(2*0)+(1*5)=92
92 % 10 = 2
So 32741-05-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H12S/c1-7(2)6-8-4-3-5-9-8/h3-5,7H,6H2,1-2H3

32741-05-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(2-methylpropyl)thiophene

1.2 Other means of identification

Product number -
Other names Thiophene, 2-(2-methylpropyl)-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:32741-05-2 SDS

32741-05-2Relevant articles and documents

Selective angiotensin II AT2 receptor agonists: Arylbenzylimidazole structure-activity relationships

Wu, Xiongyu,Wan, Yiqian,Mahalingam,Murugaiah,Plouffe, Bianca,Botros, Milad,Karlén, Anders,Hallberg, Mathias,Gallo-Payet, Nicole,Alterman, Mathias

, p. 7160 - 7168 (2006)

Structural alterations in the 2- and 5-positions of the first drug-like selective angiotensin II AT2 receptor agonist (1) have been performed. The imidazole ring system was proven to be a strong determinant for the AT2 selectivity, and with few exceptions all variations gave good AT2 receptor affinities and with retained high AT 2/AT1 selectivities. On the contrary to the findings with AT1 receptor agonists, the impact of structural modifications in the 5-position of the AT2 selective compounds were less pronounced regarding activation of the AT2 receptor. The butyloxyphenyl (56) and the propylthienyl (50) derivatives were found to exert a high agonistic effect as deduced from their capacity to induce neurite elongation in neuronal cells, as does angiotensin II.

N-acyl sulfamide FBPase inhibitor, preparation method thereof, drug composition and application

-

Paragraph 2380; 2384; 2385, (2017/09/08)

The invention discloses an N-acryl sulfamide FBPase inhibitor of a novel structure, and a preparation method thereof, a drug composition and an application, and particularly relates to an N-acryl sulfamide FBPase inhibitor shown in the formula I, a salt thereof for medicine, a preparation method, a composition comprising one or more compounds, an application of the compound in preparing the FBPase inhibitor or a drug for treating FBPase-related diseases, and an application in preparing a drug for preventing and/or treating diabetes. The formula is shown in the description.

New FBPase inhibitors for diabetes

-

Page/Page column 15, (2008/06/13)

Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R3 have the significance given in the application and which can be used in the form of pharmaceutical compositions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 32741-05-2